|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Division of Physiology and Pathophysiology (N.K., M.N., K.N., S.K., F.S., A.K.) and Division of Biological Chemistry (T.W., S.I.), School of Pharmaceutical Sciences, Kinki University, Higashi-Osaka, Japan; Department of Pharmacology and Therapeutics (M.D.H.) and Department of Physiology and Biophysics (K.C., W.K.M.), Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; and Research and Development Centre, Fuso Pharmaceutical Industries Ltd., Osaka, Japan (H.N.)
We investigated proteinase-activated receptor-2 (PAR2)-triggered signal transduction pathways causing increased prostaglandin E2 (PGE2) formation in human lung-derived A549 epithelial cells. The PAR2 agonist, SLIGRL-NH2 (Ser-Leu-Ile-Gly-Arg-Leu-amide), evoked immediate cytosolic Ca2+ mobilization and delayed (0.5-3 h) PGE2 formation. The PAR2-triggered PGE2 formation was attenuated by inhibition of the following signal pathway enzymes: cyclooxygenases 1 and 2 (COX-1 and COX-2, respectively), cytosolic Ca2+-dependent phospholipase A2 (cPLA2), the mitogen-activated protein kinases (MAPKs), mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) and p38 MAPK, Src family tyrosine kinase, epidermal growth factor (EGF) receptor tyrosine kinase (EGFRK), and protein kinase C (PKC), but not by inhibition of matrix metalloproteinases. SLIGRL-NH2 caused prompt (5 min) and transient ERK phosphorylation, blocked in part by inhibitors of PKC and tyrosine kinases but not by an EGFRK inhibitor. SLIGRL-NH2 also evoked a relatively delayed (15 min) and persistent (30 min) phosphorylation of p38 MAPK, blocked by inhibitors of Src and EGFRK but not by inhibitors of COX-1 or COX-2. SLIGRL-NH2 elicited a Src inhibitor-blocked prompt (5 min) and transient phosphorylation of the EGFRK. SLIGRL-NH2 up-regulated COX-2 protein and/or mRNA levels that were blocked by inhibition of p38 MAPK, EGFRK, Src, and COX-2 but not MEK-ERK. SLIGRL-NH2 also caused COX-1-dependent up-regulation of microsomal PGE synthase-1 (mPGES-1). We conclude that PAR2-triggered PGE2 formation in A549 cells involves a coordinated up-regulation of COX-2 and mPGES-1 involving cPLA2, increased cytosolic Ca2+, PKC, Src, MEK-ERK, p38 MAPK, Src-mediated EGF receptor trans-activation, and also metabolic products of both COX-1 and COX-2.
Address correspondence to: Dr. Atsufumi Kawabata, Division of Physiology and Pathophysiology, School of Pharmaceutical Sciences, Kinki University, 3-4-1 Kowakae, Higashi-Osaka 577-8502, Japan. E-mail: kawabata{at}phar.kindai.ac.jp
This article has been cited by other articles:
![]() |
Z.-Y. Wang, P. Wang, and D. E. Bjorling Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1127 - R1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Morla, G. Crambert, D. Mordasini, G. Favre, A. Doucet, and M. Imbert-Teboul Proteinase-activated Receptor 2 Stimulates Na,K-ATPase and Sodium Reabsorption in Native Kidney Epithelium J. Biol. Chem., October 17, 2008; 283(42): 28020 - 28028. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Saleh, T. S. Mann, T. Peters, R. J. Betts, and P. J. Henry Influence of Dexamethasone on Protease-Activated Receptor 2-Mediated Responses in the Airways J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 622 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. van der Merwe, M. D. Hollenberg, and W. K. MacNaughton EGF receptor transactivation and MAP kinase mediate proteinase-activated receptor-2-induced chloride secretion in intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G441 - G451. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, S. Wen, N. W. Bunnett, R. Leduc, M. D. Hollenberg, and W. K. MacNaughton Proteinase-activated Receptor-2 Induces Cyclooxygenase-2 Expression through -Catenin and Cyclic AMP-response Element-binding Protein J. Biol. Chem., January 11, 2008; 283(2): 809 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ostrowska, E. Sokolova, and G. Reiser PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1208 - L1218. [Abstract] [Full Text] [PDF] |
||||